Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

This strategy enables Pfizer to maintain a strong foothold in the generic drug market while also protecting its revenue ...

One might think that a pharmaceutical ingredients company that boasts clients in 80 countries, certification from several ...

In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ ...

OliX Pharmaceuticals announced a global licensing agreement with Eli Lilly (LLY). This collaboration focuses on the development and ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

For the pharmaceutical industry caught in the crosshairs of a potential trade war, the consequences of U.S. tariffs on China ...

Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new facilities, strategically positioned across key global markets ...